Clinical efficacy of Linggui Tanxue acupuncture combined with extracorporeal shock wave therapy for piriformis syndrome: a prospective comparative clinical study
In brief
Acupuncture plus shock wave halves piriformis pain scores in 2 weeks
In a small prospective trial of 60 adults with piriformis syndrome, adding Linggui Tanxue acupuncture before extracorporeal shock wave therapy lowered pain to an average VAS of 1.4 versus 3.6 with shock wave alone, and reduced muscle thickness by about 3 mm. The treatment was safe but the study lacked registration and long-term follow-up, so larger trials are needed.
- Journal
- Frontiers in medicine (Q1)
- Published
- 31 July 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Chao Xue, Jie Ma, Longlong Wei, Songgang Liu
- PMID
- 42602886
- DOI
- 10.3389/fmed.2026.1897807
Why clinicians should know about it
- Picked for Complementary and Alternative Medicine (paper of the day, 18 August 2026): Acupuncture + ESWT RCT for piriformis syndrome
Abstract
OBJECTIVE: To evaluate the short-term clinical efficacy and safety of Linggui Tanxue acupuncture combined with extracorporeal shock wave therapy (ESWT) in patients with piriformis syndrome (PS). METHODS: Sixty patients with PS aged 35 to 45 years were prospectively allocated using a random-number table into a control group receiving ESWT alone and a combined-treatment group receiving Linggui Tanxue acupuncture followed by ESWT, with 30 patients in each group. The treatment course lasted 2 weeks. Visual analogue scale (VAS) pain scores, musculoskeletal ultrasound (MSUS)-measured piriformis muscle thickness, clinical efficacy category, and adverse events were evaluated. Pain assessment and ultrasound measurement were performed by assessors blinded to treatment allocation. Because the study was not prospectively registered and no predefined statistical analysis plan or formal sample size calculation was established before initiation, the analysis should be interpreted as exploratory. RESULTS: Baseline sex distribution, age, disease duration, VAS scores, and piriformis muscle thickness were comparable between groups (all p > 0.05). After 2 weeks, both groups showed significant reductions in VAS scores and piriformis muscle thickness (both p < 0.001). The combined-treatment group showed significantly greater improvement than the ESWT-alone control group in the two continuous outcomes: post-treatment VAS score was lower in the combined-treatment group (1.44 ± 0.10 vs. 3.57 ± 0.17; mean difference, -2.12; 95% CI, -2.20 to -2.05; p < 0.001), and post-treatment piriformis thickness was also lower (9.04 ± 0.16 mm vs. 12.16 ± 0.25 mm; mean difference, -3.13 mm; 95% CI, -3.23 to -3.02; p < 0.001). The combined-treatment group also had a significantly higher total effective rate than the control group (86.7% vs. 46.7%; Fisher exact p = 0.002), but this categorical outcome was considered supportive and should be interpreted cautiously. No serious adverse events occurred. CONCLUSION: Linggui Tanxue acupuncture combined with ESWT may provide greater short-term pain relief and greater ultrasound-measured improvement in piriformis muscle thickness than ESWT alone in patients with PS. The findings are encouraging but not definitive because of the absence of prospective registration, lack of a predefined statistical analysis plan, lack of formal sample size calculation, and the short 2-week follow-up period. Larger prospectively registered multicenter studies with predefined statistical analysis plans, formal sample size calculations, and longer follow-up are warranted.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.